AYUMI PHARMACEUTICAL CORP has a total of 20 patent applications. It increased the IP activity by 500.0%. Its first patent ever was published in 2001. It filed its patents most often in Australia, Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and measurement are OXAGEN LTD, GUDMUNDSSON KRISTJAN and CENERX BIOPHARMA INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 5 | |
#2 | Canada | 2 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | United States | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 2 | |
#6 | Brazil | 1 | |
#7 | China | 1 | |
#8 | United Kingdom | 1 | |
#9 | Republic of Korea | 1 | |
#10 | Malaysia | 1 | |
#11 | Norway | 1 | |
#12 | Philippines | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Measurement | |
#4 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Heterocyclic compounds | |
#4 | Analysing materials | |
#5 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Aono Hiroyuki | 10 |
#2 | Seki Iwao | 7 |
#3 | Yamazaki Yusuke | 7 |
#4 | Shirae Satoshi | 7 |
#5 | Yamamoto Minoru | 7 |
#6 | Imamura Miwa | 7 |
#7 | Kawashima Kenji | 7 |
#8 | Tanaka Tomomi | 7 |
#9 | Kato Masatomo | 4 |
#10 | Mori Toshiyuki | 4 |
Publication | Filing date | Title |
---|---|---|
WO2020246120A1 | Orally disintegrating tablet and manufacturing method therefor | |
CN110914280A | 6H-thieno [2,3-e ] [1,2,4] triazolo [3,4-c ] [1,2,4] triaza derivatives | |
GB201518757D0 | Inhibition of IL-2 production |